📰 Generic Competition News
Generic Competition News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Generic Competition. Real-time updates on events, politics, business and more.
May 2, 2024
Unveiling the Financial and Strategic Landscape Post Q1 2024
May 1, 2024
Unveiling the Financial and Strategic Position of Eli Lilly and Co in 2024
May 1, 2024
Revenue Declines Amidst Generic Competition, Yet Strategic Initiatives Show Promise
February 27, 2024
Insightful Analysis of Biomarin's Market Position and Future Prospects
February 22, 2024
Insightful Analysis of United Therapeutics Corp's Financial Health and Strategic Position
February 22, 2024
Insightful Analysis of Eli Lilly's Market Position and Future Prospects
February 7, 2024
Full Year 2023 Revenue Drops by 24% as Company Navigates Commercial and Regulatory Hurdles
September 14, 2023
The drugmaker, which currently has six candidates in trials, will advance six more in its research pipeline - including three cell therapies that target immune system disorders and different types of cancer. The New York-based company has been pressured by declining demand for two of its top drugs, the blood cancer treatment Revlimid and blood thinner Eliquis, which face generic competition. Bristol and partner Pfizer's blood thinner Eliquis was also on the list of 10 drugs that will be s...